MYLERAN (Aspen Global Inc.)


Welcome to the PulseAid listing for the MYLERAN drug offered from Aspen Global Inc.. This Alkylating Activity [MoA],Alkylating Drug [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Aspen Global Inc.
NON-PROPRIETARY NAME: busulfan
SUBSTANCE NAME: BUSULFAN
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Alkylating Activity [MoA],Alkylating Drug [EPC]
ROUTE: ORAL
DOSAGE FORM: TABLET, FILM COATED
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 1985-03-21
END MARKETING DATE: 0000-00-00


MYLERAN HUMAN PRESCRIPTION DRUG Details:

Item DescriptionMYLERAN from Aspen Global Inc.
LABELER NAME: Aspen Global Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 2(mg/1)
START MARKETING DATE: 1985-03-21
END MARKETING DATE: 0000-00-00
PRODUCT ID: 76388-713_5fcf4541-4b08-407d-b67f-6ac95f759f90
PRODUCT NDC: 76388-713
APPLICATION NUMBER: NDA009386

Other BUSULFAN Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
American Regent, Inc.N/A
Aspen Global Inc.MYLERAN
Otsuka America Pharmaceutical, Inc.BUSULFEX
Pharmascience Inc.Busulfan
Sagent PharmaceuticalsBusulfan